NCT Number: NCT04025372
Phase: Phase 2
Trial Summary: This research study is comparing the use of a new form of hormonal therapy used with radiation as a possible treatment for intermediate risk prostate cancer. More specifically, thi – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s):
Acronym:
INTREPId (INTermediate Risk Erection PreservatIon Trial)
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives